The liaison between respiratory failure and high blood pressure: evidence from COVID-19 patients

Eur Respir J. 2020 Jul 30;56(1):2001157. doi: 10.1183/13993003.01157-2020. Print 2020 Jul.

Abstract

In COVID-19 patients respiratory failure is associated with increased systemic blood pressure, conceivably due to the modulation of the renin-angiotensin-aldosterone system by SARS-CoV-2 infection https://bit.ly/3cINsHB

Publication types

  • Letter
  • Observational Study

MeSH terms

  • Aged
  • Betacoronavirus
  • COVID-19
  • COVID-19 Drug Treatment
  • Coronavirus Infections / complications*
  • Coronavirus Infections / drug therapy
  • Disease Progression
  • Drug Combinations
  • Female
  • Hemodynamics
  • Humans
  • Hydroxychloroquine / administration & dosage
  • Hypertension / complications*
  • Italy
  • Lopinavir / administration & dosage
  • Male
  • Middle Aged
  • Oxygen
  • Pandemics
  • Pneumonia, Viral / complications*
  • Renin-Angiotensin System
  • Respiratory Insufficiency / complications*
  • Ritonavir / administration & dosage
  • SARS-CoV-2
  • Treatment Outcome

Substances

  • Drug Combinations
  • lopinavir-ritonavir drug combination
  • Lopinavir
  • Hydroxychloroquine
  • Ritonavir
  • Oxygen